AND — Andlauer Healthcare Income Statement
0.000.00%
Last trade - 00:00
- CA$1.70bn
- CA$1.82bn
- CA$647.95m
- 91
- 39
- 77
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 290 | 314 | 440 | 648 | 648 |
Cost of Revenue | |||||
Gross Profit | 169 | 183 | 238 | 326 | 319 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 245 | 263 | 366 | 538 | 552 |
Operating Profit | 45 | 50.9 | 73.7 | 110 | 96.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 42.3 | 46.6 | 108 | 104 | 90.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 30.3 | 37.7 | 90 | 76.3 | 66.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 29.8 | 37.7 | 90 | 76.3 | 66.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.8 | 37.7 | 90 | 76.3 | 66.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.792 | 0.98 | 2.25 | 1.79 | 1.55 |
Dividends per Share |